This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second Look: A broad discussion on the use of 3D cell cultures and organs-on-a-chip to review their future use in research

Ticker(s): TMO, LZAGY, AVTR, GLW

Who's the expert?

Institution: University of Central Florida

  • Associate Professor of Medicine at the Burnett School of Biomedical Sciences at University of Central Florida.
  • Co-founder of Cyto-Sen Therapeutics, now Kiadis, a Sanofi company which specializes in innate immunity with emphasis on cell biology of Natural Killer (NK) cells in the context of immunotherapy for treatment of cancer.
  • Laboratory has developed a nanoparticle-based platform for NK cell expansion that is simple, safe, economical and effective. 

Interview Questions
Q1.

Describe your current research setting

Added By: ben_admin
Q2.

How have you utilized 3D cell cultures in your research?

Added By: ben_admin
Q3.

What companies are at the forefront of innovation in the 3D cell culture space?

Added By: ben_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.